World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
45360
World Ranking
5981
National Ranking
227

Pieter E. Postmus publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pieter E. Postmus sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 607 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pieter E. Postmus D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pieter E. Postmus sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pieter E. Postmus is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on medicine, with a significant number of publications in pulmonary and respiratory medicine as well as oncology and related biomedical fields.

Their published works span several key areas including lung cancer treatments and mutations, lung cancer diagnosis and treatment, cancer genomics and diagnostics, renal cell carcinoma treatment, effects of radiation exposure, RNA modifications and cancer, and cancer immunotherapy and biomarkers.

Recent papers by Pieter E. Postmus include the following:

  • The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer, 2020, Journal of Thoracic Oncology
  • Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing, 2020, Journal of Thoracic Oncology
  • Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach, 2021, EClinicalMedicine
  • Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer, 2021, Histopathology
  • The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study, 2020, Cancer Treatment and Research Communications

Pieter E. Postmus frequently collaborates with a number of coauthors, including:

  • Daniëlle Cohen
  • Jan H. von der Thüsen
  • Liesbeth M. Hondelink
  • S.R.S. Ramai
  • Bart P.C. Hoppe

Their research is often published in several prominent venues, notably:

  • Journal of Thoracic Oncology
  • Histopathology
  • American Journal of Respiratory and Critical Care Medicine
  • EClinicalMedicine
  • Cancer Treatment and Research Communications

Best Publications

  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

    Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim

  • The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Ramón Rami-Porta;David Ball;John Crowley;Dorothy J. Giroux

  • Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

    Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan

  • Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

    Berend J Slotman;Corinne Faivre-Finn;Gijs Kramer;Elaine M Rankin

  • Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

    Harm Van Tinteren;Otto S. Hoekstra;Egbert F. Smit;Jan H.A.M. Van Den Bergh

  • Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

    Serge A van Wolferen;Johannes T Marcus;Anco Boonstra;Koen M J Marques

  • The international association for the study of lung cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer

    Frances A. Shepherd;John J. Crowley;Paul Van Houtte;Pieter E. Postmus

  • Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

    Andrea Ardizzoni;Heine Hansen;Per Dombernowsky;Teresa Gamucci

  • The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

    Eric Vallières;Frances A. Shepherd;John J. Crowley;Paul Van Houtte

  • Prognostic factors in patients with pleural mesothelioma : The European Organization for Research and Treatment of Cancer Experience

    D Curran;T Sahmoud;P Therasse;J van Meerbeeck

  • Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

    Frederick Arce Vargas;Andrew J S Furness;Kevin Litchfield;Kroopa Joshi

  • Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

    Klaas Kok;Jan Osinga;Ben Carritt;Mary B. Davis

  • Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.

    Frederick Arce Vargas;Andrew J.S. Furness;Andrew J.S. Furness;Isabelle Solomon;Kroopa Joshi;Kroopa Joshi

  • Current aspects of spontaneous pneumothorax

    F. M. N. H. Schramel;P. E. Postmus;R. G. J. R. A. Vanderschueren

  • Noninvasively Assessed Pulmonary Artery Stiffness Predicts Mortality in Pulmonary Arterial Hypertension

    C. Tji-Joong Gan;Jan-Willem Lankhaar;Nico Westerhof;J. Tim Marcus

  • Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer

    Ramaswamy Govindan;Aleksandra Szczesna;Myung Ju Ahn;Claus Peter Schneider

  • Right ventricular diastolic impairment in patients with pulmonary arterial hypertension

    Silvia Rain;M Louis Handoko;Pia Trip;C Tji-Joong Gan

  • Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension.

    C Tji-Joong Gan;Jan-Willem Lankhaar;J Tim Marcus;Nico Westerhof

  • Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

    Astrid A.M. Van der Veldt;Mark Lubberink;Mark Lubberink;Idris Bahce;Maudy Walraven

Frequent Co-Authors

Egbert F. Smit
Egbert F. Smit VU University Medical Center
Anton Vonk-Noordegraaf
Anton Vonk-Noordegraaf Amsterdam University Medical Centers
Nico Westerhof
Nico Westerhof VU University Medical Center
Peter J.F. Snijders
Peter J.F. Snijders Vrije Universiteit Amsterdam
Suresh Senan
Suresh Senan University of Amsterdam
Fred H. Menko
Fred H. Menko Netherlands Cancer Institute
Otto S. Hoekstra
Otto S. Hoekstra Amsterdam UMC
Andrea Ardizzoni
Andrea Ardizzoni University of Bologna
Martin Reck
Martin Reck LungenClinic Grosshansdorf
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a range of related careers and flexible online degrees. Many students consider alternative healthcare roles or bridging programs that align with their career goals and personal circumstances. For those interested in nursing, there are direct entry msn programs online—these are designed for non-nurses seeking a fast-track to an advanced nursing degree without starting from scratch.

If you’re concerned about tough admission standards, you might explore easiest nursing programs to get into. These schools typically have more flexible requirements, giving more students a chance to start their nursing career.

Those attracted to administrative healthcare roles may want to learn about financial aid for medical billing and coding. This can make programs in billing and coding accessible, even if you’re concerned about tuition costs.

Finally, for prospective nurses who want to avoid lengthy entry exams, there are options such as an lpn program without teas test. These programs make entering healthcare more attainable for those anxious about standardized test requirements.

Best Scientists Citing Pieter E. Postmus

Trending Scientists

Recently Published Articles